Grants
Research in the Division of Epidemiology is funded by intramural grants from within Mayo Clinic and by grants from the National Institutes of Health, industry partners, research foundations external to Mayo Clinic and others.
Samuel O. Antwi, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Principal investigator |
Genetic and Epigenetic Drivers of HCC Development in the Setting of NAFLD (Mayo Clinic Hepatobiliary Cancer SPORE — Career Enhancement) |
Mayo Clinic Inter-SPORE Developmental Award |
02/01/19-08/31/21 |
| Principal investigator |
Elucidating 5-Methylcytosine and 5-Hydroxymethylcytosine Potential for Early Diagnosis of PDAC |
Mayo Clinic Inter-SPORE Developmental Award |
09/01/18-08/31/19 |
Suzette J. Bielinski, Ph.D., M.Ed.
| Role |
Grant Title |
Funding Source |
Duration |
| Principal investigator |
Harnessing the Electronic Health Record to Predict Risk of Cardiovascular Disease (R01 HL136659) |
National Heart, Lung, and Blood Institute |
12/15/17-11/30/21 |
| Principal investigator |
Right Drug, Right Dose, Right Time Protocol (RIGHT Protocol) |
Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery and Mayo Clinic Center for Individualized Medicine (CSHCD/CIM RIGHT 10K) |
01/01/12-12/31/19 |
James R. Cerhan, M.D., Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Principal investigator |
Iowa Population-Based Cancer Epidemiology Research Center: Consortium University of Iowa (N01 PC35143) |
National Cancer Institute |
05/01/18-04/30/28 |
| Co-principal investigator |
Genetic Predictors of Early Clinical Failure in DLBCL (R01 CA212162) |
National Cancer Institute |
08/01/17-07/31/22 |
| Co-principal investigator |
Genomic Predictors of Early Relapse in Immunochemotherapy-Treated Follicular Lymphoma (P50 CA97274 — Project 4 of Lymphoma Specialized Program of Research Excellence) |
National Cancer Institute |
09/01/17-06/30/22 |
| Principal investigator |
Genetic Epidemiology of Non-Hodgkin's Lymphoma (R01 CA200703) |
National Cancer Institute |
07/08/16-05/31/21 |
| Co-principal investigator |
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (U01 CA195568) |
National Cancer Institute |
06/23/15-05/31/20 |
| Subcontract principal investigator |
Metabolism of Follicular Lymphoma (LRF-FLPG) |
Lymphoma Research Foundation |
03/01/16-02/28/19 |
Alanna M. Chamberlain, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Subcontract principal investigator |
Using PCORnet to Compare Blood Pressure Control Strategies (PaCR-2017C2-8153) |
Patient-Centered Outcomes Research Institute |
08/01/18-06/30/21 |
| Principal investigator |
Identification and Characterization of High-Cardiovascular Risk Patients Meeting the Repatha Target Patient Profile (EPI-241624) |
EpidStat Institute |
07/16/18-07/15/19 |
| Principal investigator |
Development of a Claims-Based Algorithm to Identify Heart Failure Patients with Preserved Ejection Fraction (EPI-238637) |
EpidStat Institute |
05/24/18-05/23/19 |
Ellen L. Goode, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Subcontract principal investigator |
Epidemiology and Biology of lncRNAs in Ovarian Cancer (R01 CA207456) |
National Cancer Institute |
09/01/16-08/31/21 |
| Principal investigator |
Epidemiology and Genomics of Ovarian Clear Cell Carcinoma (R21 CA222867) |
National Cancer Institute |
08/01/18-07/31/20 |
Steven Goodison, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Principal investigator |
Translation of a Clinical Molecular Diagnostic Assay for Bladder Cancer (R01 CA206584) |
National Cancer Institute |
08/01/17-07/31/22 |
| Principal investigator |
Towards a Non-Invasive Molecular Test for Bladder Cancer (R01 CA116161) |
National Cancer Institute |
04/01/15-03/31/20 |
| Principal investigator |
Development of Homogeneous Immunoassay Sensors for the Detection Of Disease Markers and Toxins at 0.1 ng/mL Within 30 Minutes |
Plexense, Inc. |
07/01/17-12/31/19 |
| Principal investigator |
NMR Spectroscopy to Identify Candidate Biomarkers for Bladder Cancer Detection |
Pilot and Feasibility Grant from the Mayo Clinic Metabolomics Resource Core |
06/01/18-05/30/19 |
Hilal Maradit Kremers, M.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Principal investigator |
Risk of Cognitive Impairment and Dementia in Total Joint Arthroplasty (R01 AG60920) |
National Institute on Aging |
03/01/19-11/30/23 |
| Principal investigator |
Cardiotoxicity in Total Joint Arthroplasty (R01 HL147155) |
National Heart, Lung, and Blood Institute |
07/19/19-06/30/23 |
| Principal investigator |
Enhance Arthroplasty Research Through Electronic Health Records and NLP-enabled Informatics (R01 AR073147) |
National Institute of Arthritis and Musculoskeletal and Skin Diseases |
03/01/18-02/28/23 |
Michelle M. Mielke, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Co-principal investigator |
Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease (U54 AG044170) |
National Institute on Aging |
09/30/18-05/31/23 |
| Subcontract principal investigator |
Blood Biomarkers as Surrogate Endpoints of Treatment Responses to Aerobic Exercise and/or Cognitive Training in Amnestic Mild Cognitive Impairment (R01 AG059654) |
National Institute on Aging |
08/01/18-05/31/22 |
| Principal investigator |
Reproductive Risk Factors for Alzheimer's Disease Dementia and Pathology (RF1 AG055151) |
National Institute on Aging |
05/01/17-04/30/22 |
| Principal investigator |
Addressing Scientific Knowledge Gaps in Alzheimer's Disease. A Retrospective Data Analysis |
Biogen |
01/12/18-06/11/20 |
| Principal investigator |
Sphingolipids and Inflammation in the Development and Progression of Alzheimer's (R01 AG049704) |
National Institute on Aging |
09/01/15-04/30/20 |
| Principal investigator |
Targeting Tau Phosphorylation and Missorting to Treat Alzheimer's Disease (P007104501) |
Minnesota Partnership for Biotechnology And Medical Genomics |
02/01/18-01/31/20 |
| Co-principal investigator |
Alzheimer's Disease Patient Registry (U01 AG06786) |
National Institute on Aging |
07/01/14-06/30/19 |
Janet E. Olson, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Co-principal investigator |
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology Project (R21 AG058738) |
National Institute on Aging |
08/01/18-07/31/20 |
Gloria M. Petersen, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Principal investigator |
Intercepting Pancreatic Cancer in High-Risk Cohorts |
Stand Up To Cancer |
02/01/18-01/31/22 |
| Principal investigator |
Determinants of Pancreatic Cancer And Malignant Melanoma Phenotypes in CDKN2A Hereditary Kindreds (R01 CA208517) |
National Cancer Institute |
08/17/16-07/31/21 |
| Principal investigator |
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer (U01 CA210138) |
National Cancer Institute |
07/15/16-06/30/21 |
| Principal investigator |
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer (Administrative Supplement for Coordinating Center) (U01 CA210138) |
National Cancer Institute |
07/15/16-06/30/21 |
| Principal investigator |
Validation and Fine-Scale Mapping of Pancreatic Cancer Susceptibility Loci (R01 CA154823) |
National Cancer Institute |
04/01/16-03/31/21 |
| Principal investigator |
Mayo Clinic SPORE in Pancreatic Cancer (P50 CA102701) |
National Cancer Institute |
09/18/14-08/31/19 |
| Principal investigator |
Mayo Cancer Genetic Epidemiology Training Program (R25 CA092049) |
National Cancer Institute |
08/01/14-07/31/19 |
| Principal investigator |
Validation and Temporal Performance of Pancreatic Cancer Biomarkers in Prospective Cohorts (17-80-PETE) |
Pancreatic Cancer Action Network |
07/01/17-06/30/19 |
Walter A. Rocca, M.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Co-principal investigator |
Multiple Chronic Conditions and Aging (R01 AG052425) |
National Institute on Aging |
04/01/17-03/31/22 |
| Co-principal investigator |
Multimorbidity and Aging: Rochester Epidemiology Project (R01 AG034676) |
National Institute on Aging |
09/30/15-05/31/20 |
Mark E. Sherman, M.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Co-principal investigator |
The Sister Study & Sister Study (A) (PHR-SS-S-18-005474) |
National Institute of Environmental Health Sciences |
08/23/18-08/22/23 |
| Co-principal investigator |
Predicting Breast Cancer Risk After a Benign Percutaneous Biopsy (R01 CA229811) |
National Cancer Institute |
07/05/18-06/30/23 |
Jennifer St. Sauver, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Co-principal investigator |
Multiple Chronic Conditions and Aging (R01 AG052425) |
National Institute on Aging |
04/01/17-03/31/22 |
| Co-principal investigator |
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology Project (R21 AG058738) |
National Institute on Aging |
08/01/18-07/31/20 |
| Co-principal investigator |
Multimorbidity and Aging: Rochester Epidemiology Project (R01 AG034676) |
National Institute on Aging |
09/30/15-05/31/20 |
Celine M. Vachon, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Co-principal investigator |
Breast Cancer Screening Cohort for Training and Validation of GRAIL Assay (GRAIL-002-CSP) |
GRAIL |
01/01/17-12/31/22 |
| Subcontract principal investigator |
Endogenous Hormones and Postmenopausal Breast Cancer: Etiologic Insights and Improving Risk Prediction (R01 CA207369) |
National Institutes of Health |
04/01/18-03/31/22 |
| Subcontract principal investigator |
Digital Breast Tomosynthesis Imaging Biomarkers for Breast Cancer Risk Estimation (R01 CA161749) |
National Cancer Institute |
04/01/17-03/31/22 |
| Co-principal investigator |
Radiomic Phenotypes of Breast Parenchyma and Association With Breast Cancer Risk and Detection (R01 CA207084) |
National Cancer Institute |
04/01/17-03/31/22 |
| Principal investigator |
Behavioral and Psychological Impact of Returning Breast Density Results to Latinas (R01 MD09682) |
National Institute on Minority Health and Health Disparities |
04/08/16-11/30/20 |
| Subcontract principal investigator |
Collagen Structural Changes as an Early Biomarker for Breast Carcinoma (R01 CA199996) |
National Cancer Institute |
09/01/15-08/31/20 |
| Subcontract principal investigator |
Candidate Gene Resequencing of Germline Multiple Myeloma (R21 CA209533) |
National Cancer Institute |
09/01/17-08/31/19 |
| Co-principal investigator |
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response (R01 CA177150) |
National Cancer Institute |
09/01/13-08/31/19 |
| Co-principal investigator |
Mayo Cancer Genetic Epidemiology Training Program (R25 CA092049) |
National Cancer Institute |
08/01/14-07/31/19 |
| Co-principal investigator |
Molecular Characterization of Myeloma and Related Asymptomatic Precursor Conditions (R01 CA186646) |
National Cancer Institute |
07/01/14-05/31/19 |
Maria Vassilaki, M.D., Ph.D., M.P.H.
| Role |
Grant Title |
Funding Source |
Duration |
| Subcontract principal investigator |
Pathways Linking Neuropsychiatric Symptoms with Alzheimer's Disease Neuroimaging Biomarkers and the Outcome of Incident Mild Cognitive Impairment/Dementia (R01 AG057708) |
National Institute on Aging |
05/01/18-02/28/22 |
| Co-principal investigator |
Addressing Scientific Knowledge Gaps in Alzheimer's Disease. A Retrospective Data Analysis |
Biogen |
01/12/18-06/11/20 |
| Principal investigator |
Mayo-Roche Research Collaboration on MCI and Dementia-Related Risk Factors and Outcomes |
Roche |
12/01/16-05/31/20 |
Ping Yang, M.D., Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Subcontract principal investigator |
Targeting BCAT1 and Branched-Chain Amino Acid Metabolism for the Detection and Prevention of SCLC (U01 CA224293) |
National Cancer Institute |
09/10/18-08/31/23 |
| Co-principal investigator |
Advancing Cancer Pharmacoepidemiology Research Through EHRs and Informatics (U24 CA194215) |
National Cancer Institute |
05/01/18-08/31/21 |
| Subcontract principal investigator |
Evaluation of Genetic, Clinical, and Environmental Risk Factors to Establish Effective Screening Strategies for Second Primary Lung Cancer (R37 CA226081) |
National Cancer Institute |
01/01/19-04/30/20 |
| Subcontract principal investigator |
Noninvasive Detection of Circulating RNAs for Monitoring Early-Stage Non-Small Cell Lung Cancer Recurrence and Metastasis (R33 CA191245) |
National Cancer Institute |
09/01/15-08/31/18 |
Kathleen J. Yost, Ph.D.
| Role |
Grant Title |
Funding Source |
Duration |
| Principal investigator |
Using an Electronic Patient-Reported Outcome (ePRO) System to Monitor Pain, Inform Targeted Post-Surgical Opioid Prescribing, and Improve Patient Self-Management |
Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery |
02/01/18-07/31/19 |
| Principal investigator |
Finalizing the Surgery Algorithms for the CAHPS Cancer Care Survey |
Mayo Clinic Small Grants Program |
06/22/17-06/21/19 |